Skip to content
Friday, 20 November 2026
Inspire.News

Unveiling truth, one story at a time

Semaglutide cuts childhood obesity rates in trial but may stunt growth, study shows

Semaglutide cuts childhood obesity rates in trial but may stunt growth, study shows
Image: Kenya Today

A trial of the weight‑loss drug semaglutide found nearly 40% of children aged six to 11 no longer obese after 68 weeks, while also showing reduced height gain and higher gastrointestinal side effects.

Full story

Continue reading this story on Kenya Today, the publisher that reported it.

Read the full story at Kenya Today ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from National · Kenya

See all